Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.562
+0.002 (0.32%)
Aug 30, 2024, 3:47 PM EDT - Market closed
Arch Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | 2023 | 2022 | 2021 | 2020 | 2019 |
| Aug '24 Aug 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 2 | 6 | 5 | 31 | 33 | 41 | |
| Market Cap Growth | -1.33% | 27.13% | -84.42% | -7.53% | -19.65% | -38.67% | |
| Enterprise Value | 12 | 12 | 6 | 29 | 32 | 38 | |
| Last Close Price | 0.56 | 1.30 | 3.84 | 26.00 | 34.65 | 48.00 | |
| PE Ratio | - | -0.57 | -0.87 | -4.58 | -6.94 | -8.78 | |
| PS Ratio | 21.02 | 80.51 | 306.38 | 2660.92 | - | - | |
| PB Ratio | -0.30 | -0.81 | -1.14 | -30.00 | -22.18 | -51.30 | |
| P/FCF Ratio | -1.03 | -1.80 | -1.08 | -5.16 | -6.59 | -7.86 | |
| P/OCF Ratio | -1.03 | -1.81 | -1.08 | -5.16 | -6.60 | -7.86 | |
| EV/Sales Ratio | 80.03 | 159.75 | 405.09 | 2473.36 | - | - | |
| EV/EBITDA Ratio | -2.50 | -2.40 | -1.11 | -4.49 | -5.99 | -6.01 | |
| EV/EBIT Ratio | -2.50 | -2.40 | -1.11 | -4.49 | -5.98 | -6.00 | |
| EV/FCF Ratio | -3.18 | -3.58 | -1.42 | -4.80 | -6.34 | -7.26 | |
| Debt / Equity Ratio | -0.75 | -0.75 | -0.80 | -1.56 | -0.51 | - | |
| Debt / FCF Ratio | -2.53 | -1.67 | -0.75 | -0.27 | -0.15 | - | |
| Asset Turnover | 0.10 | 0.03 | 0.00 | 0.00 | - | - | |
| Inventory Turnover | 0.07 | 0.06 | 0.04 | 0.03 | - | - | |
| Quick Ratio | 0.00 | 0.02 | 0.22 | 1.31 | 1.53 | 3.05 | |
| Current Ratio | 0.10 | 0.21 | 0.78 | 2.12 | 3.41 | 4.05 | |
| Return on Equity (ROE) | - | - | - | - | - | -1646.09% | |
| Return on Assets (ROA) | -199.27% | -138.22% | -113.63% | -136.79% | -132.39% | -102.87% | |
| Return on Capital (ROIC) | - | - | - | - | - | -1441.50% | |
| Earnings Yield | -519.81% | -114.54% | -110.02% | -20.28% | -14.10% | -10.98% | |
| FCF Yield | -148.26% | -55.42% | -92.92% | -19.37% | -15.17% | -12.72% | |
| Buyback Yield / Dilution | -339.38% | -156.27% | -9.05% | -16.99% | -13.05% | -8.92% | |
| Total Shareholder Return | -339.38% | -156.27% | -9.05% | -16.99% | -13.05% | -8.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.